Advertisement

Topics

EU regulators greenlight U.S. biotech Aveo's kidney cancer drug

04:55 EDT 23 Jun 2017 | Reuters

(Reuters) - European regulators on Friday recommended the approval of Aveo Pharmaceuticals Inc's drug to treat kidney cancer, marking a big victory for the U.S. biotech that has faced a number of setbacks in bringing the drug to the market.

Original Article: EU regulators greenlight U.S. biotech Aveo's kidney cancer drug

NEXT ARTICLE

More From BioPortfolio on "EU regulators greenlight U.S. biotech Aveo's kidney cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...